相关实验视频

Updated: Jun 3, 2025

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

PcoCas12a:一种来自Prevotella copri的新型CRISPR酶,可以增强TCR-T细胞瘤抑制

Qiang Guo¹, Lei Huang², Yi Liu¹

¹College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; BGI Research, Hangzhou 310030, China; BGI Research, Shenzhen 518083, China.

International journal of biological macromolecules

|January 12, 2025

概括

研究人员发现了CRISPR/PcoCas12a,这是一种来自Prevotella copri.的新型基因编辑酶. 这种酶在编辑免疫细胞方面表现出卓越的效率,增强了T细胞治疗癌症的疗法.

科学领域:

分子生物学分子生物学
免疫学免疫学免疫学
基因治疗基因治疗

背景情况:

基因组编辑对于细胞工程和基因治疗至关重要.
对于免疫细胞应用而言,仍然需要一种最佳的基因编辑酶.

研究的目的:

确定和描述一种用于免疫细胞应用的新型基因编辑酶.
评估新型酶在增强基于T细胞的癌症治疗中的有效性.

主要方法:

来自Prevotella copri.的CRISPR/PcoCas12a酶的识别和特征.
在T细胞中PcoCas12a和AsCas12a编辑效率的比较.
在TCR-T细胞中PcoCas12a介导的DGKα淘汰的评估,用于瘤抑制.
单细胞测序以分析T细胞激活和免疫反应.

主要成果:

CRISPR/PcoCas12a识别了5'-YYN PAM序列,并且显示了比AsCas12a更广泛的编辑位置和更高的效率.
通过PcoCas12a介导的DGKα淘汰显著增强T细胞抗瘤活性.
与AsCas12a相比,使用PcoCas12a的DGKα淘汰赛显示出更高的淘汰效率和瘤抑制.
单细胞测序证实PcoCas12a通过增强激活和免疫反应来改善T细胞瘤抑制能力.

结论:

CRISPR/PcoCas12a是一种高效的T细胞基因编辑酶.
在癌症治疗中,PcoCas12a对推进T细胞治疗具有显著的潜力.

关键词:

免疫治疗是一种免疫疗法.这是一种新的基因编辑酶.单细胞测序是一种单细胞测序.

更多相关视频

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...